InhaleRX gains approval for clinical trial to test non-opioid therapy for cancer pain
InhaleRX Ltd has received approval for a Phase 2 clinical trial to test its novel therapy IRX-211 for treatment of Breakthrough Cancer Pain
Corporate Spotlight
Not Yet Available
Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.
Latest Threads
Tag | Subject | ||||||
---|---|---|---|---|---|---|---|
RCO | Ann: Half Year Accounts | 08/03/19 | 0 | 108 | |||
|
|||||||
RCO | Ann: Quarterly Activities and Cashflow Reports | 31/01/19 | 0 | 220 | |||
|
|||||||
RCO | Ann: Results of Meeting | 13:26 | 0 | 102 | |||
|
|||||||
RCO | Ann: Quarterly Activities and Cash flow Reports | 23/10/18 | 0 | 140 | |||
|
|||||||
RCO | Royalties are the way to go | 19/10/18 | 1 | 331 | |||
|
|||||||
RCO | Ann: Notice of General Meeting/Proxy Form | 15/10/18 | 0 | 108 | |||
|
|||||||
RCO | Ann: Annual Report to shareholders | 15/10/18 | 0 | 139 | |||
|
|||||||
RCO | Ann: Corporate Governance Statement | 15/10/18 | 0 | 92 | |||
|
See All Discussions